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Probability of Significant Coronary Artery Disease
W. Bob Meijboom, MD,*† Carlos A. G. van Mieghem, MD,*† Nico R. Mollet, MD, PHD,*†
Francesca Pugliese, MD,*† Annick C. Weustink, MD,*† Niels van Pelt, MD,*†
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Objectives We assessed the usefulness of 64-slice computed tomography coronary angiography (CTCA) to detect or rule out
coronary artery disease (CAD) in patients with various estimated pretest probabilities of CAD.
Background The pretest probability of the presence of CAD may impact the diagnostic performance of CTCA.
Methods Sixty-four-slice CTCA (Sensation 64, Siemens, Forchheim, Germany) was performed in 254 symptomatic pa-
tients. Patients with heart rates 65 beats/min received beta-blockers before CTCA. The pretest probability for
significant CAD was estimated by type of chest discomfort, age, gender, and traditional risk factors and defined
as high (71%), intermediate (31% to 70%), and low (30%). Significant CAD was defined as the presence of
at least 1 50% coronary stenosis on quantitative coronary angiography, which was the standard of reference.
No coronary segments were excluded from analysis.
Results The estimated pretest probability of CAD in the high (n  105), intermediate (n  83), and low (n  66) groups
was 87%, 53%, and 13%, respectively. The diagnostic performance of the computed tomography (CT) scan was
different in the 3 subgroups. The estimated post-test probability of the presence of significant CAD after a nega-
tive CT scan was 17%, 0%, and 0% and after a positive CT scan was 96%, 88%, and 68%, respectively.
Conclusions Computed tomography coronary angiography is useful in symptomatic patients with a low or intermediate estimated
pretest probability of having significant CAD, and a negative CT scan reliably rules out the presence of significant CAD.
Computed tomography coronary angiography does not provide additional relevant diagnostic information in symptom-
atic patients with a high estimated pretest probability of CAD. (J Am Coll Cardiol 2007;50:1469–75) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.07.007p
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She estimated pretest probability of having significant coro-
ary artery disease (CAD) in a study population should be
aken into account in the evaluation of the diagnostic accuracy
f computed tomography coronary angiography (CTCA) to
etect or rule out the presence of coronary stenosis. The
stimated pretest probability of having obstructive CAD in
atients who present with chest pain is related to age, gender,
ype of chest discomfort, and traditional risk factors. The
stimated pretest probability is lowest in younger female
rom the *Department of Cardiology, Thoraxcenter, Rotterdam, the Netherlands; and
Department of Radiology, Erasmus Medical Center, Rotterdam, the Netherlands.t
Manuscript received March 14, 2007; revised manuscript received July 2, 2007,
ccepted July 10, 2007.atients with nonanginal chest pain and highest in older male
atients with typical angina (1).
The diagnostic performance of CTCA has mostly been
ested in symptomatic patient populations with a high esti-
ated pretest probability of having significant CAD, and a few
tudies have reported on the impact of different estimated
retest probabilities on the performance of CTCA (2).
The purpose of this study was to evaluate the diagnostic
erformance and clinical usefulness of 64-slice CTCA in
54 patients with high, intermediate, or low estimated
retest probability of having significant coronary stenosis.
ethods
tudy population. During a 24-month period, 254 pa-
ients presenting with typical angina pectoris, atypical an-
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CTCA and Pretest Probability for CAD October 9, 2007:1469–75gina pectoris, and nonanginal
chest pain who were referred for
conventional coronary angiogra-
phy (CCA) were included into
the study. Typical angina was
defined as having 3 characteris-
tics: 1) substernal discomfort; 2)
that is precipitated by physical
exertion or emotion; and 3) re-
lieved with rest or nitroglycerin
within 10 min. Atypical angina
pectoris was defined as having 2
of 3 of the definition character-
istics. Nonanginal chest pain was
characterized as 1 or absence of
the described chest pain features.
The estimated pretest probability
or obstructive CAD was estimated using the Duke Clinical
core, which includes type of chest discomfort, age, gender,
nd traditional risk factors (3,4). Patients were categorized
nto a low (1% to 30%), intermediate (31% to 70%), or high
71% to 99%) estimated pretest probability group of having
ignificant CAD. No patients with previous history of percu-
aneous coronary intervention, coronary artery bypass surgery,
rior myocardial infarction, impaired renal function (serum
reatinine 120 mol/l), persistent arrhythmias, or known
llergy to iodinated contrast material were included. Conven-
ional coronary angiogram was performed before or after the
TCA and served as the standard of reference. The institu-
ional review board of the Erasmus Medical Center Rotterdam
pproved the study, and all subjects gave informed consent.
atient preparation. Patients with a heart rate exceeding
5 beats/min received additional beta-blockers (50/100 mg
etoprolol) 1 h before the computed tomography (CT)
xamination.
can protocol. All scans were performed with a 64-slice
T scanner that features a gantry rotation time of 330 ms,
temporal resolution of 165 ms, and a spatial resolution of
.4 mm3 (Sensation 64, Siemens, Forchheim, Germany). A
alcium scoring scan was performed with the following
arameters: 64  0.6 mm collimation, 330 ms rotation
ime, 120 kV tube voltage, 150 mAs tube current, 3.8
m/rotation table feed, prospective electrocardiogram
ECG) X-ray tube modulation. Afterward, the CTCA was
erformed using identical parameters aside from a higher
ube current between 850 and 960 mAs and without
he use of prospective ECG X-ray tube modulation.
he radiation exposure was estimated using dedicated
oftware (ImPACT, version 0.99x, St. George’s Hospital,
ooting, London, United Kingdom).
A bolus of 95 ml of contrast material (400 mgI/ml;
omeron, Bracco, Milan, Italy) was injected intravenously in
n antecubital vein at 5 ml/s, and a bolus-tracking technique
as used to synchronize the arrival of contrast in the
Abbreviations
and Acronyms
CAD  coronary artery
disease
CCA  conventional
coronary angiogram
CI  confidence interval
CT  computed
tomography
CTCA  computed
tomography coronary
angiography
LR  likelihood ratio
QCA  quantitative
coronary angiographyoronary arteries and the initiation of the scan. smage reconstruction. Datasets were reconstructed imme-
iately after the scan after a stepwise approach as previously
escribed (5,6). If necessary, multiple datasets of a single
atient were used separately in order to obtain optimal
mage quality for all available coronary segments.
uantitative coronary angiography (QCA). All scans
ere carried out within 1 week before or after CCA. One
xperienced cardiologist, unaware of the results of CTCA,
dentified and analyzed all coronary segments, using a
7-segment modified American Heart Association classifi-
ation. All segments, regardless of size, were included for
omparison with CTCA. Segments were classified as nor-
al (smooth parallel or tapering borders), as having non-
ignificant disease (wall irregularities or 50% stenosis), or
aving significant disease (stenosis 50%). Stenoses were
valuated in the worst view, and classified as significant if
he lumen diameter reduction exceeded 50% measured by
alidated QCA algorithm (CAAS, Pie Medical, Maastricht,
he Netherlands).
T image evaluation. One observer analyzed total calcium
cores of all patients using dedicated software. Two experi-
nced observers, a radiologist and a cardiologist, unaware of
he results of CCA, evaluated the CTCA data sets on an
ffline workstation (Leonardo, Siemens) using (curved)
ultiplanar reconstruction. Segments were scored positive
or significant CAD if there was 50% diameter reduction
f the lumen by visual assessment. Segments distal to a
hronic total occlusion were excluded. Interobserver dis-
greements were resolved by a third reader.
tatistical analysis. The diagnostic performance of CTCA
or the detection of significant coronary artery stenoses as
efined by QCA is presented as sensitivity, specificity,
ositive and negative predictive values with the correspond-
ng 95% confidence intervals (CIs), and positive and nega-
ive likelihood ratios (LRs) were calculated. Comparison
etween CTCA and QCA was performed on 3 levels:
atient-by-patient, vessel-by-vessel, and segment-by-
egment analysis. A Mantel-Haenszel test was performed to
valuate the trend in sensitivity and specificity relative to the
stimated pretest probability for obstructive CAD.
Categorical characteristics are expressed as numbers and
ercentages, and compared between the 3 groups using the
hi-square test. Continuous variables are expressed as means
standard deviation) and compared with 1-way analysis of
ariance followed by post-hoc Bonferroni correction to
djust for multiple comparisons. If not normally distributed,
ontinuous variables are expressed as medians (25th to 75th
ercentile range) and compared with Kruskal-Wallis test.
An additional analysis was done to investigate the effect
f nesting since repeated assessments within the same
atient were made that were not independent observations.
random selection of a single segment per patient was
one, and the diagnostic accuracy for detecting significant
rtery disease was calculated. Interobserver and intraob-
erver variability for the detection of significant coronary
tenosis and agreement between techniques to classify pa-
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October 9, 2007:1469–75 CTCA and Pretest Probability for CADients as having no, single-, or multivessel disease was
etermined by -statistics.
esults
atient demographics are shown in Table 1. Additional
eta-blockers before CT scanning were administered in
4% (188 of 254) of patients decreasing the mean heart rate
rom 71  11 beats/min to 59  8 beats/min. The mean
can time was 12.7  1.6 s. Initially, all data sets were
econstructed in the mid- to end-diastolic phase. In 34% of
he cases (86 of 254), additional higher quality reconstruc-
ions obtained during end systole were used for evaluation.
The estimated radiation exposure using prospective X-ray
ube modulation for the calcium score in women and men
as 1.8 and 1.4 mSv, respectively. The estimated radiation
xposure for the contrast-enhanced scan without prospec-
ive X-ray tube modulation was 17.0 mSv in women and
3.4 mSv in men, which is in line with previous reports (7).
iagnostic performance of 64-slice CTCA: all patients
ith chest pain. The observed pretest probability of sig-
ificant CAD, defined as having at least 1 50% coronary
tenosis per patient was 50%. The diagnostic performance
f CTCA for detecting significant stenoses on a patient
Patient Demographics (n  254)
Table 1 Patient Demographics (n  254)
Pret
>70%
High
(n  105)
Typical angina 89 (85)
Atypical angina 16 (15)
Nonanginal chest pain 0 (0)
Men 97 (92)
Age (yrs)* 63  9
BMI (kg/m2)* 27.5  4.2
Heart rate (beats/min)* 57  8
Risk factors
Hypertension† 68 (65)
Hypercholesterolemia‡ 71 (68)
Diabetes mellitus§ 16 (15)
Current smoker 32 (30)
Previous smoker 14 (13)
Family history of CAD 57 (54)
Obesity¶ 32 (30)
Calcium score (Agatston score)# 354 (103–814
Conventional coronary angiography
Prevalence of obstructive CAD 82 (78)
Absence of CAD 6 (6)
Nonsignificant disease 17 (16)
Single-vessel disease 42 (40)
Multivessel disease 40 (38)
*Mean and standard deviation. †Blood pressure 140/90 mm Hg or
hypercholesterolemia. §Treatment with oral antidiabetic medication
second-degree relatives with premature CAD (age55 years). ¶Body m
otherwise indicated. Categorical variables were tested with chi-square
normally distributed, continuous variables were compared with Kruskevel is detailed in Table 2. Eighteen patients with angio- araphic nonsignificant disease were incorrectly classified as
aving significant CAD by CT: 17 patients were scored as
aving single-vessel disease, and 1 patient was misinter-
reted as having multivessel disease. Ninety-eight percent
124 of 126) of patients with significant CAD on CCA
ere correctly identified by CTCA (Fig. 1). The 2 patients
n whom the severity of disease was underestimated both
howed significant lumen narrowing in the circumflex cor-
nary artery (both 53% diameter reduction, 1 in the proxi-
al and 1 in the midsegment). Forty patients with single-
essel disease were evaluated as having multivessel disease by
TCA due to overestimation of disease severity in other
essels. Agreement between CTCA and QCA on a per-
atient (no or any disease) level was very good (-value:
.84), whereas agreement between techniques to classify
atients as having no, single-, and multivessel disease was
ood (-value: 0.61).
iagnostic performance of 64-slice CTCA: patient-by-
atient analysis. The analysis comprised 105 (43%) pa-
ients with a high estimated pretest probability for CAD, 83
33%) patients with an intermediate, and 66 (26%) patients
ith a low estimated pretest probability for CAD. The
ean age between patients with high estimated probability
obability of Significant CAD
p Value
30% to 70%
Intermediate
(n  83)
<30%
Low
(n  66)
31 (37) 3 (4)
29 (35) 21 (32) 0.0001
23 (28) 42 (64)
47 (57) 27 (41) 0.0001
61  8 50  12 0.0001
27.1  4.8 26.7  4.2 NS
60  7 61  7 0.01
43 (52) 30 (45) 0.05
52 (63) 14 (21) 0.0001
11 (13) 4 (6) NS
16 (19) 16 (24) NS
6 (7) 4 (6) NS
39 (47) 29 (44) NS
21 (25) 13 (20) NS
134 (1–296) 0 (0–56) 0.0001
32 (39) 12 (18) 0.0001
21 (25) 36 (55) 0.0001
30 (36) 18 (27)
22 (27) 9 (14)
10 (12) 3 (5)
nt for hypertension. ‡Total cholesterol 180 mg/dl or treatment for
lin. Family history of coronary artery disease (CAD), having first- or
ex (BMI)30 kg/m2. #Median and quartiles. Values are n (%) unless
ntinuous variables were tested with 1-way analysis of variance. If not
s test. The p values 0.05 were considered statistically significant.est Pr
)
treatme
or insu
ass ind
test. Cond intermediate estimated probability was significantly
Diagnostic Performance and Predictive Value of 64-Slice CT Coronary Angiography for the Detectionof >50% Stenosis on QCA: Analysis for High, Intermediate, and Low Pretest Likelihood for Obstructive CAD
Table 2 Diagnostic Performance and Predictive Value of 64-Slice CT Coronary Angiography for the Detectionof >50% Stenosis on QCA: Analysis for High, Intermediate, and Low Pretest Likelihood for Obstructive CAD
Observed*
Pretest
Probability, %
Estimated†
Pretest
Probability, % n TP TN FP FN Kappa Sensitivity,‡ % Specificity,§ % PPV, % NPV, % LR LR
Patient-based
analysis: all
50 — 254 124 110 18 2 0.84 98 (94–100) 86 (78–91) 87 (80–92) 98 (93–100) 7.00 0.02
High 78 87 105 80 17 6 2 0.76 98 (91–100) 74 (51–89) 93 (85–97) 89 (65–98) 3.74 0.03
Intermediate 39 53 83 32 43 8 0 0.81 100 (87–100) 84 (71–93) 80 (64–90) 100 (90–100) 6.38 0.00
Low 18 13 66 12 50 4 0 0.82 100 (70–100) 93 (81–98) 75 (47–92) 100 (91–100) 13.50 0.00
Vessel-based
analysis: all
19 — 1,016 181 730 97 8 0.71 96 (92–98) 88 (86–90) 65 (59–71) 99 (98–99) 8.16 0.05
High 31 — 420 126 229 60 5 0.68 96 (91–99) 79 (74–84) 68 (60–74) 98 (95–99) 4.63 0.05
Intermediate 13 — 332 40 261 28 3 0.67 93 (80–98) 90 (86–93) 59 (46–70) 99 (96–100) 9.60 0.08
Low 6 — 264 15 240 9 0 0.75 100 (75–100) 96 (93–98) 63 (41–80) 100 (98–100) 27.67 0.00
Segment-based
analysis: all
7 — 3,647 228 3,194 193 32 0.64 88 (83–91) 94 (93–95) 54 (49–59) 99 (99–99) 15.39 0.13
High 12 — 1,468 163 1,161 126 18 0.64 90 (85–94) 90 (88–92) 56 (50–62) 98 (98–99) 9.20 0.11
Intermediate 4 — 1,219 46 1,112 54 7 0.58 87 (74–94) 95 (94–96) 46 (36–56) 99 (99–100) 18.74 0.14
Low 3 — 960 19 921 13 7 0.65 73 (52–88) 99 (98–99) 59 (41–76) 99 (98–100) 52.50 0.27
*Observed pretest probability: based on conventional coronary angiography (1 significant coronary stenosis as determined by quantitative coronary angiography [QCA]); †estimated pretest probability: estimated using Duke Clinical Score; ‡the sensitivity showed a trend
with a lower sensitivity in the low estimated pretest probability in the per-segment analysis (p  0.05); §the specificity showed a trend with a lower specificity in the high estimated pretest probability in the per-patient, per-vessel, and per-segment analysis (p  0.05, p 
0.0001, p  0.0001, respectively). Values in parentheses represent 95% confidence intervals.
CAD  coronary artery disease; FN  false negative; FP  false positive; NPV  negative predictive value; PPV  positive predictive value; TN  true negative; TP  true positive; LR  positive likelihood ratio; LR  negative likelihood ratio.
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October 9, 2007:1469–75 CTCA and Pretest Probability for CADifferent from the mean age in the low probability group,
nd the median calcium score was significantly different in
ll 3 groups. The mean heart rate was significantly lower in
he high estimated probability group compared with those
een in the intermediate and low estimated probability
roups (Table 1).
The diagnostic performance of CTCA was different in
he patient groups with various estimated pretest probabil-
ties. The specificity showed a trend with a lower specificity
n the high estimated pretest probability (p  0.05, sensi-
ivity p  NS). The diagnostic impact of CTCA on the
stimated pretest probability of having significant CAD is
hown in Figures 2 and 3.
iagnostic performance of 64-slice CTCA: vessel-by-
essel analysis. The diagnostic performance of CTCA for
he detection of significant lesions on a vessel-based analysis
s detailed in Table 2. Two significantly diseased right
oronary arteries, 1 left anterior descending artery, and 5
iseased circumflex coronary arteries were incorrectly clas-
ified as nonsignificantly diseased by CTCA. Of a total of
,016 vessels, the severity of a lesion was overestimated in 97
onobstructive vessels (false positives). The diagnostic per-
ormance of the CT scan was different in the 3 subgroups.
he specificity showed a trend towards lower specificity in
Figure 1 CTCA Image of the Right Coronary Artery
Volume-rendered computed tomography coronary angiography (CTCA) image (A) of
the right coronary artery. A curved multiplanar reconstructed image (B) and a thick
maximum-intensity projected image (C) disclose a significant coronary stenosis
(arrows) in the midright coronary artery, which was corroborated by conventional
coronary angiogram (D). Proximally and distally of the significant obstructed lesion,
nonsignificant calcified plaques can be seen (C).he high estimated pretest probability (p  0.0001, sensi- givity p  NS). Agreement between CTCA and QCA on a
er-vessel level was good (-value: 0.71).
iagnostic performance of 64-slice CTCA: segment-by-
egment analysis. Overall, 3,647 (of 4,318 potentially
vailable segments) were included for comparison with
CA. Unavailable segments included 547 anatomically
bsent segments on CCA and 124 segments distal to an
ccluded coronary segment. Segments were not excluded for
easons such as severe calcifications or poor image quality.
he -value for interobserver and intraobserver variability
as 0.70 and 0.72, respectively. The diagnostic performance
f CTCA for detecting significant stenoses is detailed in
able 2. Agreement between CTCA and QCA on a
er-segment level was good (-value, 0.64).
The severity of 32 significant coronary stenoses was
nderestimated or missed and classified as nonsignificant by
TCA. Most of these significant lesions (24 of 32) were
ocated in distal segments or in side branches. The severity of
93 nonsignificant lesions was overestimated by CTCA. The
iagnostic performance of the CT scan was different in the 3
ubgroups with a lower sensitivity (p  0.05) and a higher
pecificity (p  0.0001) in the low pretest probability group.
Analysis on the randomly selected segments resulted in
sensitivity of 92% (24 of 26; 95% CI 73% to 99%),
pecificity of 93% (212 of 228; 95% CI 89% to 96%),
ositive predictive value of 60% (16 of 40; 95% CI 43%
o 75%), and a negative predictive value of 99% (212 of
14; 95% CI 96% to 100%). The effect of nesting is
robably minimal as the result of this analysis is very
imilar to the results shown in the per-segment analysis
Table 2).
iscussion
he diagnostic performance of 64-slice CTCA to detect or
ule out the presence of significant coronary stenosis has
ainly been reported for patients with stable angina pectoris
cheduled for invasive CCA, and these studies have shown
hat CTCA can reliably rule out significant CAD (5,8–10).
he majority of these patients presented with a high
stimated pretest probability of having significant CAD,
nd only scant information is available on the diagnostic
erformance of 64-slice CTCA in patients with a low or
ntermediate estimated pretest probability of having signif-
cant CAD.
In this study, we used the Duke Clinical Score, which
ncorporates clinical presentation of chest pain, age, gender,
nd traditional risk factors, to estimate the pretest proba-
ility of having significant CAD. Using the LRs of the tests,
hich were obtained in this study, post-test probabilities
ere calculated.
The pretest probability of CAD may impact of the
iagnostic performance of the CT scan. Indeed, the diag-
ostic performance of CTCA in the 3 groups was different.
he specificity was lower in the high pretest probability
roup compared with the low pretest probability group,
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CTCA and Pretest Probability for CAD October 9, 2007:1469–75hereas sensitivity was lower in the per-segment analysis in
he low pretest probability group. This observation can
robably be explained by the higher calcium scores in the
igher probability groups, which tend to overestimate the
everity of stenosis.
Figure 2 Impact of CTCA on Various Estimated Pretest Probab
1Estimated using Duke Clinical Score (including Diamond-Forrester criteria and pro
coronary stenosis as determined by quantitative coronary angiography); 3calculate
coronary artery disease; CTCA  computed tomography coronary angiography; Est
Figure 3 Influence of CTCA on Probability of
Obstructive CAD as a Function of Pretest Probability
Using the positive and negative likelihood ratios obtained from Table 2, we cal-
culated the estimated post-test probabilities of CAD after positive and negative
findings on CTCA from various estimated pre-test probabilities of CAD. Dashed
lines  CTCA; dotted lines  CTCA. Abbreviations as in Figure 2.pA negative CT scan was present in 75% of the patients
ith a low estimated pretest probability and in approxi-
ately 50% of the patients with an intermediate estimated
retest probability. The negative predictive value of CTCA
o exclude significant CAD was excellent in these patients,
educing the estimated post-test probability to zero. Thus,
hese patients would not need further downstream diag-
ostic tests. They may be candidates for secondary
revention measures, such as statin therapy in the pres-
nce of nonobstructive plaques or could be discharged
rom further cardiac follow-up in the absence of any
isible plaque.
A positive CT scan occurred in approximately 25% and
0% of the patients with a low or intermediate estimated
retest probability, respectively. The number of false-
ositive outcomes was rather high in these patients, which
enders a positive CT scan rather unreliable for clinical
ecision making. In these patients it may be reasonable to
roceed to invasive CCA in the case of left main disease,
-vessel disease, and in the presence of a critical stenosis in
he proximal part of a major coronary artery. In case of
essel disease in distal vessels or side branches, equivocal
esions, or uninterpretable scans, one may consider a non-
nvasive stress test to determine the functional significance
f a doubtful coronary stenosis. A negative functional test
ay overrule the clinical significance of a (false)-positive
T scan and reduce the need for invasive coronary angiog-
aphy. A positive functional test may further increase the
of Significant CAD
c clinical variables); 2based on conventional coronary angiography (1 significant
Bayesian statistics (post-test odds  pretest odds  likelihood ratio). CAD 
imated; Obs  observed.ilities
gnosti
d using
 estrobability of having significant CAD and should be fol-
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October 9, 2007:1469–75 CTCA and Pretest Probability for CADowed by invasive coronary angiography and coronary revas-
ularization if symptoms are not alleviated by the antiangi-
al mediation. However, further studies are necessary to
valuate the diagnostic value of the combination of func-
ional data from a stress test with the anatomical data
rovided by CTCA.
In the high estimated pretest probability group, a
egative CTCA reduced the estimated post-test proba-
ility to 17%, whereas a positive CTCA increased the
stimated post-test probability to as high as 96%. Given
he high estimated pretest probability of significant CAD
n this group, the majority of these symptomatic patients
re likely to proceed to invasive CCA even if CTCA is
egative, since the post-test probability of significant
AD was still 10%. Computed tomography coronary
ngiography, therefore, appears to be of limited clinical
alue in the evaluation of the high estimated pretest
robability group. Assessment for the presence of myo-
ardial ischemia with a functional test may be more
ppropriate in this situation.
tudy limitations. The studied patients were not a pro-
pective, consecutive group of patients. However, selection
as not based on particular patient demographics, but
ather on the availability of the 64-slice CT scanner for the
xamination of cardiac patients. The rather high estimated
adiation exposure of 64-slice CTCA (17 to 13.4 mSv) as
ompared with CCA (3 to 6 mSv) is of concern (7). In this
tudy we did not use prospective ECG X-ray tube modu-
ation, which can significantly reduce radiation exposure,
ut requires a regular heart rhythm and limits the possibility
f reconstructing images in the end-systolic phase. In our
tudy end-systolic data sets provided optimal image quality
n 34% of patients.
Currently, there is no validated software available able to
uantify the degree of stenoses. So far, the severity of
oronary stenosis as assessed by CT is rather crudely visually
stimated as more or less than 50% luminal diameter
tenosis.eprint requests and correspondence: Dr. Pim J. de Feyter,
rasmus Medical Center, Department of Cardiology and Radiol-
gy, Room Hs 207, P.O. Box 2040, 3000 CA Rotterdam, the
etherlands. E-mail: p.j.defeyter@erasmusmc.nl.
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